Chen C, Li M, Guo A, Guo P, Zhang W, Gu C
NPJ Vaccines. 2025; 10(1):32.
PMID: 39955275
PMC: 11829966.
DOI: 10.1038/s41541-025-01087-z.
Lin F, Yan L, Yuan X, Yang X, Yang X, Yang Y
Biomark Med. 2025; 19(3):91-99.
PMID: 39840913
PMC: 11792867.
DOI: 10.1080/17520363.2025.2453411.
Liao H, Liu S
J Biomed Sci. 2025; 32(1):10.
PMID: 39833784
PMC: 11748563.
DOI: 10.1186/s12929-024-01102-w.
Ji J, Chen L, Wu Z, Tang T, Zhu L, Zhu M
Sci Rep. 2024; 14(1):31424.
PMID: 39733119
PMC: 11682164.
DOI: 10.1038/s41598-024-83026-x.
Li N, Kumar S, Cao D, Munoz-Melero M, Arisa S, Brian B
Viruses. 2024; 16(10.
PMID: 39459842
PMC: 11512359.
DOI: 10.3390/v16101507.
DNA and RNA vaccines against tuberculosis: a scoping review of human and animal studies.
Kazakova A, Zhelnov P, Sidorov R, Rogova A, Vasileva O, Ivanov R
Front Immunol. 2024; 15:1457327.
PMID: 39421744
PMC: 11483866.
DOI: 10.3389/fimmu.2024.1457327.
Bacteria and Allergic Diseases.
Guryanova S
Int J Mol Sci. 2024; 25(19).
PMID: 39408628
PMC: 11477026.
DOI: 10.3390/ijms251910298.
The RNA receptor RIG-I binding synthetic oligodeoxynucleotide promotes pneumonia survival.
Wang Y, Kulkarni V, PantaleonGarcia J, Longmire M, Lethier M, Cusack S
JCI Insight. 2024; 9(21).
PMID: 39352770
PMC: 11601584.
DOI: 10.1172/jci.insight.180584.
Immune-modulative nano-gel-nano system for patient-favorable cancer therapy.
Kim S, Han R, Han H, Kim Y
Bioact Mater. 2024; 43:67-81.
PMID: 39328776
PMC: 11424977.
DOI: 10.1016/j.bioactmat.2024.08.047.
In Vivo Interactions of Nucleic Acid Nanostructures With Cells.
Xiao Y, Liang Z, Shyngys M, Baekova A, Cheung S, Muljadi M
Adv Mater. 2024; 37(2):e2314232.
PMID: 39263835
PMC: 11733725.
DOI: 10.1002/adma.202314232.
Revolutionizing adjuvant development: harnessing AI for next-generation cancer vaccines.
Zhang W, Zheng X, Coghi P, Chen J, Dong B, Fan X
Front Immunol. 2024; 15:1438030.
PMID: 39206192
PMC: 11349682.
DOI: 10.3389/fimmu.2024.1438030.
Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective.
Liu D, Liu L, Li X, Wang S, Wu G, Che X
Vaccines (Basel). 2024; 12(8).
PMID: 39204073
PMC: 11359700.
DOI: 10.3390/vaccines12080950.
Effects of Synthetic Toll-Like Receptor 9 Ligand Molecules on Pulpal Immunomodulatory Response and Repair after Injuries.
Quispe-Salcedo A, Yamazaki T, Ohshima H
Biomolecules. 2024; 14(8).
PMID: 39199319
PMC: 11353191.
DOI: 10.3390/biom14080931.
Adenosine deaminase 2 regulates the activation of the toll-like receptor 9 in response to nucleic acids.
Dong L, Luo W, Maksym S, Robson S, Zavialov A
Front Med. 2024; 18(5):814-830.
PMID: 39078537
DOI: 10.1007/s11684-024-1067-5.
Revolutionizing cancer therapy using tetrahedral DNA nanostructures as intelligent drug delivery systems.
Sharma A, Vaswani P, Bhatia D
Nanoscale Adv. 2024; 6(15):3714-3732.
PMID: 39050960
PMC: 11265600.
DOI: 10.1039/d4na00145a.
Peptide-based PET tracer targeting LAG-3 for evaluating the efficacy of immunotherapy in melanoma.
Yuan P, Long Y, Wei N, Wang Y, Zhu Z, Han J
J Immunother Cancer. 2024; 12(7).
PMID: 39043603
PMC: 11284866.
DOI: 10.1136/jitc-2024-009010.
Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG.
Slepenkin A, Pal S, Rasley A, Coleman M, de la Maza L
NPJ Vaccines. 2024; 9(1):104.
PMID: 38858418
PMC: 11164897.
DOI: 10.1038/s41541-024-00880-6.
Unveiling ecological/evolutionary insights in HIV viral load dynamics: Allowing random slopes to observe correlational changes to CpG-contents and other molecular and clinical predictors.
Carrasco-Hernandez R, Valenzuela-Ponce H, Soto-Nava M, Garcia-Morales C, Matias-Florentino M, Wertheim J
Epidemics. 2024; 47:100770.
PMID: 38761432
PMC: 11213286.
DOI: 10.1016/j.epidem.2024.100770.
The role of DNA in the pathogenesis of SLE: DNA as a molecular chameleon.
Pisetsky D, Herbert A
Ann Rheum Dis. 2024; 83(7):830-837.
PMID: 38749573
PMC: 11168871.
DOI: 10.1136/ard-2023-225266.
Antibodies Induced by Smallpox Vaccination after at Least 45 Years Cross-React with and In Vitro Neutralize Mpox Virus: A Role for Polyclonal B Cell Activation?.
Mariotti S, Venturi G, Chiantore M, Teloni R, De Santis R, Amendola A
Viruses. 2024; 16(4).
PMID: 38675961
PMC: 11054675.
DOI: 10.3390/v16040620.